These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. PSK immunotherapy in cancer patients--a preliminary report. Chung CH, Go P, Chang KH. Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1987 Aug; 20(3):210-6. PubMed ID: 3322700 [Abstract] [Full Text] [Related]
3. Anticancer effects and mechanisms of polysaccharide-K (PSK): implications of cancer immunotherapy. Fisher M, Yang LX. Anticancer Res; 2002 Aug; 22(3):1737-54. PubMed ID: 12168863 [Abstract] [Full Text] [Related]
8. [Randomized controlled study on adjuvant immunochemotherapy with PSK in curatively resected colorectal cancer. The Cooperative Study Group of Surgical Adjuvant Immunochemotherapy for Cancer of Colon and Rectum]. Mitomi T, Tsuchiya S, Iijima N, Aso K, Suzuki K, Nishiyama K, Amano T, Takahashi T, Murayama N, Oka H. Gan To Kagaku Ryoho; 1989 Jun; 16(6):2241-9. PubMed ID: 2500070 [Abstract] [Full Text] [Related]
9. [Clinical results of a randomized controlled trial on the effect of adjuvant immunochemotherapy using Esquinon and Krestin in patients with curatively resected gastric cancer--7-year survival--Cooperative Study Group for Cancer Immunochemotherapy, Tokai Gastrointestinal Oncology Group]. Ichihashi H, Kondo T, Nakazato H. Gan To Kagaku Ryoho; 1987 Sep; 14(9):2758-66. PubMed ID: 3307635 [Abstract] [Full Text] [Related]
10. Effectiveness of immunochemotherapy with PSK, a protein-bound polysaccharide, in colorectal cancer and changes of tumor marker. Kudo S, Tanaka J, Kashida H, Tamegai Y, Endo S, Yamano HO. Oncol Rep; 2002 Sep; 9(3):635-8. PubMed ID: 11956642 [Abstract] [Full Text] [Related]
11. [The effect of PSK on laryngeal cancer]. Saito H, Hozawa J, Kamata S, Hakamada M, Kasahara M, Takagi A. Gan To Kagaku Ryoho; 1982 Jul; 9(6):1061-7. PubMed ID: 7184440 [Abstract] [Full Text] [Related]
14. Immunotherapy for esophageal cancer. A randomized trial in combination with radiotherapy and radiochemotherapy. Cooperative Study Group for Esophageal Cancer in Japan. Ogoshi K, Satou H, Isono K, Mitomi T, Endoh M, Sugita M. Am J Clin Oncol; 1995 Jun; 18(3):216-22. PubMed ID: 7747709 [Abstract] [Full Text] [Related]
17. [Evaluation of immunotherapy with PSK in esophageal cancer]. Ogoshi K. Gan To Kagaku Ryoho; 1988 Nov; 15(11):3143-51. PubMed ID: 3056280 [Abstract] [Full Text] [Related]
18. [A cooperative study of alternating immunochemotherapy with futraful and PSK (second report)--3-year survival rate]. Ichihashi H, Kondo T, Yamauchi M, Isomatsu T, Nakamura T, Sakabe T, Nakajima T, Ikenaga T, Shiratori T, Taguchi T. Gan To Kagaku Ryoho; 1985 Feb; 12(2):331-6. PubMed ID: 3918509 [Abstract] [Full Text] [Related]
19. [Adjuvant immunotherapy for carcinoma of uterine cervix with PSK]. Shiraki S, Mori H, Ito A, Kadomoto N, Yamagiwa S, Yamada Y, Noda K. Gan To Kagaku Ryoho; 1982 Jul; 9(6):1031-9. PubMed ID: 6985193 [Abstract] [Full Text] [Related]
20. Postoperative adjuvant immunochemotherapy and infiltration of dendritic cells for patients with advanced gastric cancer. Tsujitani S, Kakeji Y, Orita H, Watanabe A, Kohnoe S, Baba H, Anai H, Maehara Y, Sugimachi K. Anticancer Res; 1992 Jul; 12(3):645-8. PubMed ID: 1622120 [Abstract] [Full Text] [Related] Page: [Next] [New Search]